MRVI 250117 17.50C (MRVI250117C17500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

MRVI250117C17500

Watchlist

0.13
0.000.00%

15min DelayTrading Sep 19 12:30 ET

0.00High0.00Low

Intraday

5D
Daily

News

Guggenheim Initiates Maravai LifeSciences(MRVI.US) With Hold Rating
Moomoo NewsDec 20 13:31 ET · Ratings
Maravai Lifesciences Initiated With a Neutral at Guggenheim
Yahoo FinanceDec 20 07:15 ET
Danaher, Cryoport, Sartorius Win Buy as Guggenheim Expands Bioprocessing Coverage
Seeking AlphaDec 19 14:15 ET
Guggenheim Initiates Coverage on Maravai Lifesciences With Neutral Rating
MT NewswiresDec 19 07:36 ET
Express News | Maravai LifeSciences Holdings Inc - Co's Unit Pre-Paid $228 Million of Term Loan
ReutersDec 18 16:36 ET
Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating
Moomoo NewsDec 6 09:33 ET · Ratings

Comments

Stock_Drift

Sep 24 07:16

$Maravai LifeSciences (MRVI.US)$

Moomoo AI

Apr 6 09:07

Despite Maravai LifeSciences Holdings' significant liabilities, it has net cash, indicating a light debt load. However, its pre-interest and tax loss and declining revenue raise future earnings and balance sheet health concerns.

Is Maravai LifeSciences Holdings (NASDAQ:MRVI) Using Debt In A Risky Way?

Moomoo AI

Dec 21, 2023 06:11

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 06:02

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 05:43

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?